These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16702880)

  • 21. The synergistic effect of maltose enhances the anti-melanogenic activity of acarbose.
    Bin BH; Kim ST; Bhin J; Byoun K; Lee TR; Cho EG
    Arch Dermatol Res; 2017 Apr; 309(3):217-223. PubMed ID: 28185012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting.
    ; Winchester B; Bali D; Bodamer OA; Caillaud C; Christensen E; Cooper A; Cupler E; Deschauer M; Fumić K; Jackson M; Kishnani P; Lacerda L; Ledvinová J; Lugowska A; Lukacs Z; Maire I; Mandel H; Mengel E; Müller-Felber W; Piraud M; Reuser A; Rupar T; Sinigerska I; Szlago M; Verheijen F; van Diggelen OP; Wuyts B; Zakharova E; Keutzer J
    Mol Genet Metab; 2008 Mar; 93(3):275-81. PubMed ID: 18078773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling of cooked starch digestion process using recombinant human pancreatic α-amylase and maltase-glucoamylase for in vitro evaluation of α-glucosidase inhibitors.
    Cao X; Zhang C; Dong Y; Geng P; Bai F; Bai G
    Carbohydr Res; 2015 Sep; 414():15-21. PubMed ID: 26162745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
    Wang Z; Okamoto P; Keutzer J
    Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment.
    Yang CF; Liu HC; Hsu TR; Tsai FC; Chiang SF; Chiang CC; Ho HC; Lai CJ; Yang TF; Chuang SY; Lin CY; Niu DM
    Am J Med Genet A; 2014 Jan; 164A(1):54-61. PubMed ID: 24243590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactobacillus strains isolated from infant faeces possess potent inhibitory activity against intestinal alpha- and beta-glucosidases suggesting anti-diabetic potential.
    Panwar H; Calderwood D; Grant IR; Grover S; Green BD
    Eur J Nutr; 2014 Oct; 53(7):1465-74. PubMed ID: 24414142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzymatic diagnosis of Pompe disease: lessons from 28 years of experience.
    Niño MY; Wijgerde M; de Faria DOS; Hoogeveen-Westerveld M; Bergsma AJ; Broeders M; van der Beek NAME; van den Hout HJM; van der Ploeg AT; Verheijen FW; Pijnappel WWMP
    Eur J Hum Genet; 2021 Mar; 29(3):434-446. PubMed ID: 33162552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory.
    Goldstein JL; Young SP; Changela M; Dickerson GH; Zhang H; Dai J; Peterson D; Millington DS; Kishnani PS; Bali DS
    Muscle Nerve; 2009 Jul; 40(1):32-6. PubMed ID: 19533645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the molecular defect in infantile and adult acid alpha-glucosidase deficiency fibroblasts.
    Beratis NG; LaBadie GU; Hirschhorn K
    J Clin Invest; 1978 Dec; 62(6):1264-74. PubMed ID: 34626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acarbose (alpha-glucosidase inhibitor) on disaccharase activity in small intestine in KK-Ay and ddY mice.
    Miura T; Koide T; Ohichi R; Kako M; Usami M; Ishihara E; Yasuda N; Ishida H; Seino Y; Tanigawa K
    J Nutr Sci Vitaminol (Tokyo); 1998 Jun; 44(3):371-9. PubMed ID: 9742458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary Flavonoids and Acarbose Synergistically Inhibit α-Glucosidase and Lower Postprandial Blood Glucose.
    Zhang BW; Li X; Sun WL; Xing Y; Xiu ZL; Zhuang CL; Dong YS
    J Agric Food Chem; 2017 Sep; 65(38):8319-8330. PubMed ID: 28875706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acarbose and 1-deoxynojirimycin inhibit maltose and maltooligosaccharide hydrolysis of human small intestinal glucoamylase-maltase in two different substrate-induced modes.
    Breitmeier D; Günther S; Heymann H
    Arch Biochem Biophys; 1997 Oct; 346(1):7-14. PubMed ID: 9328278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-Glucosidase in Pompe's disease.
    Broadhead DM; Butterworth J
    J Inherit Metab Dis; 1978; 1(4):153-4. PubMed ID: 41974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Human and Rat Sucrase and Maltase Activities To Assess Antiglycemic Potential: Optimization of the Assay Using Acarbose and Polyphenols.
    Pyner A; Nyambe-Silavwe H; Williamson G
    J Agric Food Chem; 2017 Oct; 65(39):8643-8651. PubMed ID: 28914528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular study on the infantile form of Pompe disease in Chinese in Taiwan.
    Lin CY; Shieh JJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):115-21. PubMed ID: 8935410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: A Spanish cohort.
    Gutiérrez-Rivas E; Bautista J; Vílchez JJ; Muelas N; Díaz-Manera J; Illa I; Martínez-Arroyo A; Olivé M; Sanz I; Arpa J; Fernández-Torrón R; López de Munáin A; Jiménez L; Solera J; Lukacs Z
    Neuromuscul Disord; 2015 Jul; 25(7):548-53. PubMed ID: 25998610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study.
    Reynolds TM; Tylee K; Booth K; Wierzbicki AS; ;
    J Clin Pathol; 2019 Dec; 72(12):805-809. PubMed ID: 31308256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of black tea and its combination with acarbose on small intestinal α-glucosidase activity.
    Satoh T; Igarashi M; Yamada S; Takahashi N; Watanabe K
    J Ethnopharmacol; 2015 Feb; 161():147-55. PubMed ID: 25523370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remarkably low fibroblast acid α-glucosidase activity in three adults with Pompe disease.
    Wens SC; Kroos MA; de Vries JM; Hoogeveen-Westerveld M; Wijgerde MG; van Doorn PA; van der Ploeg AT; Reuser AJ
    Mol Genet Metab; 2012 Nov; 107(3):485-9. PubMed ID: 23000108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis of Pompe's disease (type II glycogenosis) in chorionic villus biopsy using maltose as a substrate.
    Park HK; Kay HH; McConkie-Rosell A; Lanman J; Chen YT
    Prenat Diagn; 1992 Mar; 12(3):169-73. PubMed ID: 1589418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.